Human norovirus exhibits strain-specific sensitivity to host interferon pathways in human intestinal enteroids.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
22 09 2020
Historique:
pubmed: 11 9 2020
medline: 18 11 2020
entrez: 10 9 2020
Statut: ppublish

Résumé

Human noroviruses (HuNoVs) are the leading cause of viral gastroenteritis worldwide; yet currently, no vaccines or FDA-approved antiviral drugs are available to counter these pathogens. To understand HuNoV biology and the epithelial response to infection, we performed transcriptomic analyses, RT-qPCR, CRISPR-Cas9 modification of human intestinal enteroid (HIE) cultures, and functional studies with two virus strains (a pandemic GII.4 and a bile acid-dependent GII.3 strain). We identified a predominant type III interferon (IFN)-mediated innate response to HuNoV infection. Replication of both strains is sensitive to exogenous addition of IFNs, suggesting the potential of IFNs as therapeutics. To obtain insight into IFN pathway genes that play a role in the antiviral response to HuNoVs, we developed knockout (KO) HIE lines for IFN alpha and lambda receptors and the signaling molecules,

Identifiants

pubmed: 32907944
pii: 2010834117
doi: 10.1073/pnas.2010834117
pmc: PMC7519316
doi:

Substances chimiques

Interferons 9008-11-1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

23782-23793

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI144297
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI116497
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK056338
Pays : United States
Organisme : NIAID NIH HHS
ID : HHSN272201700081C
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES030285
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA125123
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK007664
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI057788
Pays : United States

Déclaration de conflit d'intérêts

Competing interest statement: M.K.E. is named as an inventor on patents related to cloning and cultivation of the Norwalk virus genome and is a consultant to and received research funding from Takeda Vaccines, Inc. R.L.A. has received research funding from Takeda Vaccines, Inc.

Références

PLoS Pathog. 2019 Sep 19;15(9):e1008009
pubmed: 31536612
Virus Genes. 1996;12(3):287-90
pubmed: 8883366
PLoS Pathog. 2010 Mar 26;6(3):e1000831
pubmed: 20360972
J Biol Chem. 2020 May 15;295(20):6811-6822
pubmed: 32273341
Virology. 2006 Sep 30;353(2):463-73
pubmed: 16843517
Viruses. 2019 Oct 18;11(10):
pubmed: 31635238
J Virol. 2017 Mar 13;91(7):
pubmed: 28077655
Cytokine. 2008 Sep;43(3):336-41
pubmed: 18694646
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Gastroenterology. 2002 Jun;122(7):1967-77
pubmed: 12055602
Antimicrob Agents Chemother. 2018 Apr 26;62(5):
pubmed: 29530841
J Virol. 2007 Nov;81(22):12111-8
pubmed: 17855555
mBio. 2019 Oct 1;10(5):
pubmed: 31575769
Science. 2014 Jan 3;343(6166):84-87
pubmed: 24336571
Science. 2007 Jun 8;316(5830):1484-8
pubmed: 17510325
Nat Med. 2003 May;9(5):548-53
pubmed: 12692541
Emerg Infect Dis. 2013 Aug;19(8):1198-205
pubmed: 23876403
PLoS Biol. 2004 Dec;2(12):e432
pubmed: 15562321
J Clin Microbiol. 2008 Dec;46(12):4011-7
pubmed: 18842942
Nat Commun. 2018 Apr 16;9(1):1485
pubmed: 29662124
PLoS Pathog. 2019 Oct 31;15(10):e1008057
pubmed: 31671153
J Gen Virol. 2019 Oct;100(10):1393-1406
pubmed: 31483239
Viruses. 2019 Jul 11;11(7):
pubmed: 31336765
Science. 2003 Mar 7;299(5612):1575-8
pubmed: 12624267
Curr Opin Infect Dis. 2018 Oct;31(5):422-432
pubmed: 30102614
Expert Opin Ther Targets. 2016 Dec;20(12):1425-1432
pubmed: 27681264
Annu Rev Virol. 2016 Sep 29;3(1):591-609
pubmed: 27482897
J Virol. 2016 Sep 12;90(19):8906-23
pubmed: 27466422
PLoS One. 2015 Dec 03;10(12):e0142927
pubmed: 26632843
Trends Genet. 2013 Oct;29(10):569-74
pubmed: 23810203
mBio. 2020 Mar 17;11(2):
pubmed: 32184238
Sci Rep. 2017 Oct 3;7(1):12621
pubmed: 28974702
Clin Microbiol Infect. 2014 Aug;20(8):717-23
pubmed: 25040790
Science. 2014 Nov 7;346(6210):755-9
pubmed: 25378626
Front Immunol. 2017 Apr 21;8:459
pubmed: 28484457
Cell Host Microbe. 2017 Aug 9;22(2):176-184
pubmed: 28799903
J Virol. 2018 Apr 13;92(9):
pubmed: 29467318
mBio. 2020 Mar 17;11(2):
pubmed: 32184242
Nature. 2014 Jan 30;505(7485):691-5
pubmed: 24284630
Proc Natl Acad Sci U S A. 2020 Jan 21;117(3):1700-1710
pubmed: 31896578
J Gen Virol. 2016 Sep;97(9):2291-2300
pubmed: 27412790
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Sci Rep. 2018 May 29;8(1):8341
pubmed: 29844362
Emerg Infect Dis. 2019 Sep;25(9):1730-1735
pubmed: 31441758
FEMS Microbiol Lett. 2005 Dec 1;253(1):1-8
pubmed: 16168575
Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9822-7
pubmed: 17517620
Nucleic Acids Res. 2014;42(16):10668-80
pubmed: 25122750
PLoS Pathog. 2020 Apr 30;16(4):e1008515
pubmed: 32353085
Emerg Infect Dis. 2018 Aug;24(8):1453-1464
pubmed: 30014841
Front Immunol. 2019 Oct 17;10:2394
pubmed: 31681286
Gastroenterology. 2018 Dec;155(6):1898-1907
pubmed: 30170116
J Virol. 2007 Nov;81(22):12238-48
pubmed: 17855551
Am J Transl Res. 2019 Jun 15;11(6):3365-3374
pubmed: 31312350
Cell Mol Gastroenterol Hepatol. 2020;10(2):245-267
pubmed: 32289501
Antiviral Res. 2018 Jul;155:48-59
pubmed: 29753657
F1000Res. 2016 Jun 17;5:1408
pubmed: 27441086
J Virol. 2019 Feb 19;93(5):
pubmed: 30541861
Pharmacol Ther. 2012 Jul;135(1):44-53
pubmed: 22484806
Cell Mol Gastroenterol Hepatol. 2019;7(3):686-688.e5
pubmed: 30543870
Science. 2016 Sep 23;353(6306):1387-1393
pubmed: 27562956
Lancet Infect Dis. 2014 Aug;14(8):725-730
pubmed: 24981041
Science. 2020 Jul 3;369(6499):50-54
pubmed: 32358202
Virology. 2015 May;479-480:75-84
pubmed: 25724417
Viruses. 2020 Apr 06;12(4):
pubmed: 32268591
Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E570-E579
pubmed: 28069942
Cell Stem Cell. 2013 Dec 5;13(6):653-8
pubmed: 24315439
Front Immunol. 2015 Jan 09;5:655
pubmed: 25620967
Sci Adv. 2019 Mar 06;5(3):eaau4255
pubmed: 30854425
J Infect Dis. 2002 May 1;185(9):1335-7
pubmed: 12001052
Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1672-1677
pubmed: 28137842
Nat Protoc. 2015 Dec;10(12):1939-47
pubmed: 26513671

Auteurs

Shih-Ching Lin (SC)

Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.

Lin Qu (L)

Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.

Khalil Ettayebi (K)

Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.

Sue E Crawford (SE)

Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.

Sarah E Blutt (SE)

Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.

Matthew J Robertson (MJ)

Advanced Technology Cores, Baylor College of Medicine, Houston, TX 77030.

Xi-Lei Zeng (XL)

Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.

Victoria R Tenge (VR)

Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.

B Vijayalakshmi Ayyar (BV)

Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.

Umesh C Karandikar (UC)

Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.

Xiaomin Yu (X)

Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.

Cristian Coarfa (C)

Advanced Technology Cores, Baylor College of Medicine, Houston, TX 77030.
Duncan Cancer Center-Biostatistics, Baylor College of Medicine, Houston, TX 77030.
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030.

Robert L Atmar (RL)

Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.
Department of Medicine, Baylor College of Medicine, Houston, TX 77030.

Sasirekha Ramani (S)

Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.

Mary K Estes (MK)

Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030; mestes@bcm.edu.
Department of Medicine, Baylor College of Medicine, Houston, TX 77030.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH